3Konukoglu D, Firtina S, Serin O. The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance[ J ]. Metabolism ,2008, 57 (1) : 110-115.
4Jiang D J, Jiang JL, Tan GS, et al. Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level [ J ]. Planta Med,2003, 69(12) :1150-1152.
5Chen MF, Xie XM, Yang TL, et al. Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin Ⅱ [J]. J Vasc Res,2007, 44 (5) :391-402.
6Jiang JL, Wang S, Li NS, et al. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells [ J ]. Biochem Cell Biol, 2007, 85 (1): 66-77.
7Jia S J, Jiang DJ, Hu CP, et al. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells [ J ]. Vascul Pharmacol, 2006, 44(3) : 143-148.
8Suda O, Tsutsui M, Morishita T, et al. Asymmetric dimethylarginine pro- duces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress [ J ]. Arterio- scler Thromb Vasc Biol, 2004, 24 (9) : 1682-1688.
9Jiang D J, Jia S J, Dai Z, et al. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3- dependent signaling pathway in endothelial cells[ J]. J Mol Cell Cardiol, 2006, 40(4) :529-539.
10Pope A J, Druhan L, Guzman JE, et al. Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation[ J]. Am j Physiol Cell Physio1,2007, 293 ( 5 ) : C1679-C1686.
3Boger RH, Bode-Bger SM, Kienke S, Stan AC, Nafe R, Frolich JC. Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits[J]. Atherosclerosis, 1998, 136(1):67-77.
4Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, et al. Vascular smooth muscle and nitric oxide synthase[J]. FASEB J, 2002, 16(6):500-508.
5Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells[J]. J Clin Invest, 1989, 83(5):1774-1777.
6Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor[J]. Cardiovasc Res, 2003, 59(4):824-833.
7Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells[J]. J Biol Chem, 1997, 272(25):15642-15649.
8Sindermann JR, Fan L, Weigel KA, Troyer D, Müller JG, Schmidt A, et al. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture[J]. Atherosclerosis, 2000, 150(2):331-341.
9McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, et al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis[J]. Semin Thromb Hemost, 1996, 22(2):139-144.
10Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis[J]. Circulation, 1999, 99(9):1141-1146.
3WellerRO, Hawkes CA, Kalaria RN, et al. White matter changes in dementia: role of impaired drainage of interstitial fluid[J]. Brain Pathol, 2015, 25 (1): 63-78.
4Tanaka N, Katayama Y, Katayama T, et al. Effects of long term administration of HMG-COA reeducates inhibitor on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats [ J ]. Brain Res, 2007, 1169 : 125 - 132.
5Lawrence AJ, Patel B, Morris RG, et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George' s Cognition and Neuroimaging in Stroke (SCANS) study[J]. PLoSOne, 2013, 8(4): e61014.
6Kidwell CS, E1-Saden S, Livshits Z, et al. Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease[ J ]. J Neuroimaging, 2001, 11 (3) : 229 -235.
7Pantoni L. Pathophysiology of age-related cerebral white matter changes [ J ]. Cerebrovasc Dis, 2002, 13 ( Suppl 2) : 7 - 10.
8Boyaci A, Tutoglu A, Boyaci N, et al. Assessment of lower extremity arterial blood flow in females with knee osteoarthritis [ J ]. Clin Rheumatol, 2015, 34(2): 329-335.
9Lee KY, Sohn YH, Balk JS, et al. Arterial pulsatility as an index of cerebral microangiopathy in diabetes [ J ]. Stroke, 2000, 31(5): 1111-1115.
10Barkhof F, Schehens P. Imaging of white matter lesions [ J]. Cerebrovasc Dis, 2002, 13 ( Suppl 2) : 21 - 30.
